CYTORI THERAPEUTICS, INC. 4
4 · CYTORI THERAPEUTICS, INC. · Filed Jun 15, 2016
Insider Transaction Report
Form 4
HARRIS JOHN DAVID
VP and GM Cell Therapy
Transactions
- Exercise of In-Money
Subscription Rights (Right to Buy)
2016-06-15−2,500→ 0 totalExercise: $2.55From: 2016-05-26Exp: 2016-06-10→ See Footnote (2,500 underlying) - Exercise of In-Money
Common Stock
2016-06-15+2,500→ 4,500 total - Exercise of In-Money
Warrants (Right to Buy)
2016-06-15+1,250→ 1,250 totalExercise: $3.06From: 2016-06-15Exp: 2018-12-14→ Common Stock (1,250 underlying)
Footnotes (2)
- [F1]The common stock and the warrants reported on this Form 4 were acquired pursuant to the exercise of subscription rights previously distributed by Cytori Therapeutics, Inc. (the "Company) to all holders of the Company's common stock. The subscription rights entitled each recipient thereof to purchase units ("Units"). Each Unit consists of one share of the Company's common stock and 0.5 of a warrant, with each warrant representing the right to purchase one share of the Company's common stock. The purchase price for each Unit was $2.55.
- [F2]Each warrant entitles the holder to purchase one share of the Company's common stock at an exercise price of $3.06 from the date of issuance through December 14, 2018.